Tags

Type your tag names separated by a space and hit enter

Cannabinoid replacement therapy (CRT): Nabiximols (Sativex) as a novel treatment for cannabis withdrawal.
Clin Pharmacol Ther. 2015 Jun; 97(6):571-4.CP

Abstract

Cannabis is a common recreational drug that is generally considered to have low addictive potential. However, an increasing number of cannabis users are seeking treatment for dependence on the drug. There is interest in using agonist (substitution) pharmacotherapies to treat cannabis dependence and here we outline a novel approach involving a buccal spray (nabiximols) that contains tetrahydrocannabinol (THC) and cannabidiol (CBD). We review recent research with nabiximols and highlight findings relevant to clinical practice.

Authors+Show Affiliations

Psychopharmacology Laboratory, School of Psychology, Faculty of Science, University of Sydney, NSW, Australia. Discipline of Addiction Medicine, Faculty of Medicine, University of Sydney, NSW, Australia.Discipline of Addiction Medicine, Faculty of Medicine, University of Sydney, NSW, Australia. Drug and Alcohol Services, South East Sydney Local Health District, New South Wales Health, NSW, Australia.National Cannabis Prevention and Information Centre, UNSW Medicine, Australia.Drug & Alcohol Clinical Services, Hunter New England Local Health District, New South Wales Ministry of Health, Australia. School of Medicine and Public Health, Faculty of Health, University of Newcastle, Australia.Psychopharmacology Laboratory, School of Psychology, Faculty of Science, University of Sydney, NSW, Australia.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

25777582

Citation

Allsop, D J., et al. "Cannabinoid Replacement Therapy (CRT): Nabiximols (Sativex) as a Novel Treatment for Cannabis Withdrawal." Clinical Pharmacology and Therapeutics, vol. 97, no. 6, 2015, pp. 571-4.
Allsop DJ, Lintzeris N, Copeland J, et al. Cannabinoid replacement therapy (CRT): Nabiximols (Sativex) as a novel treatment for cannabis withdrawal. Clin Pharmacol Ther. 2015;97(6):571-4.
Allsop, D. J., Lintzeris, N., Copeland, J., Dunlop, A., & McGregor, I. S. (2015). Cannabinoid replacement therapy (CRT): Nabiximols (Sativex) as a novel treatment for cannabis withdrawal. Clinical Pharmacology and Therapeutics, 97(6), 571-4. https://doi.org/10.1002/cpt.109
Allsop DJ, et al. Cannabinoid Replacement Therapy (CRT): Nabiximols (Sativex) as a Novel Treatment for Cannabis Withdrawal. Clin Pharmacol Ther. 2015;97(6):571-4. PubMed PMID: 25777582.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Cannabinoid replacement therapy (CRT): Nabiximols (Sativex) as a novel treatment for cannabis withdrawal. AU - Allsop,D J, AU - Lintzeris,N, AU - Copeland,J, AU - Dunlop,A, AU - McGregor,I S, Y1 - 2015/04/17/ PY - 2015/01/16/received PY - 2015/03/05/accepted PY - 2015/3/18/entrez PY - 2015/3/18/pubmed PY - 2015/8/13/medline SP - 571 EP - 4 JF - Clinical pharmacology and therapeutics JO - Clin Pharmacol Ther VL - 97 IS - 6 N2 - Cannabis is a common recreational drug that is generally considered to have low addictive potential. However, an increasing number of cannabis users are seeking treatment for dependence on the drug. There is interest in using agonist (substitution) pharmacotherapies to treat cannabis dependence and here we outline a novel approach involving a buccal spray (nabiximols) that contains tetrahydrocannabinol (THC) and cannabidiol (CBD). We review recent research with nabiximols and highlight findings relevant to clinical practice. SN - 1532-6535 UR - https://www.unboundmedicine.com/medline/citation/25777582/Cannabinoid_replacement_therapy__CRT_:_Nabiximols__Sativex__as_a_novel_treatment_for_cannabis_withdrawal_ L2 - https://doi.org/10.1002/cpt.109 DB - PRIME DP - Unbound Medicine ER -